Efficacy of commercial Mycoplasma gallisepticum bacterin (MG-Bac) in preventing air-sac lesions in chickens.
One-week-old chickens were vaccinated with commercial Mycoplasma gallisepticum bacterin subcutaneously and challenged with the S6 strain by the intra-air-sac route 3 weeks later. Significantly fewer vaccinated chickens had air-sac lesions than controls.
D000400:Air Sacs / Q000382:microbiology*; D000818:Animals; D001428:Bacterial Vaccines / Q000276:immunology*; D002645:Chickens / Q000382:microbiology*; D008297:Male; D009174:Mycoplasma / Q000276:immunology / Q000302:isolation & purification; D009175:Mycoplasma Infections / Q000517:prevention & control / Q000662:veterinary*; D011201:Poultry Diseases / Q000517:prevention & control*; D012141:Respiratory Tract Infections / Q000517:prevention & control / Q000662:veterinary
D001428:Bacterial Vaccines